Physician profile
Joseph J Bennett
NPI 1619967841
$3,496.17
in general payments reported to CMS, 2019-2025
9 companies · $1,040 in 2025
The $1,040 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,180 · 2020: $1,093 · 2021: $84.10 · 2023: $79.53 · 2024: $19.48 · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,061 · Travel and Lodging: $78.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,060.96 |
| Travel and Lodging | $78.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $1,029.36 | 2020 | |
| Angiodynamics, INC. | $910.34 | 2019-2025 | Solero |
| Intuitive Surgical, INC. | $709.20 | 2019-2025 | |
| Ethicon US, LLC | $306.10 | 2019-2025 | Echelon; Endopath, Harmonic, Vistaseal |
| Davol INC. | $199.06 | 2020-2025 | Phasix Mesh |
| Beone Medicines USA, INC. | $146.17 | 2025 | Brukinsa |
| Ethicon Endo-Surgery INC. | $109.33 | 2019 | |
| Olympus America INC. | $67.13 | 2019 | |
| Boston Scientific Corporation | $19.48 | 2024 | Spyglass Discover |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.